• Libraries
    Icon image 1
    Signaling Pathways and Protein Classes Related Libraries
    • Angiogenesis Related Ligands
    • Apoptosis Related Ligands
    • Cancer Immunology Related Ligands
    • Cell Cycle Related Ligands
    • Epigenetics Related Ligands
    • GPCR-binding Ligands
    • Growth Factors and Cytokines Ligands
    • Hippo signaling pathway ligands
    • Ion Channel Ligands
    • JAK-STAT Signaling Ligands
    • Kinase Inhibitors
    • Kinase Inhibitors Max
    • Membrane Receptor Ligands
    • Neuronal Signaling Related Ligands
    • Nuclear Hormone Receptor Ligands
    • Protease Inhibitors
    • RNA-Binders
    • RNA-Binding Protein Ligands
    • Signal Transduction Related Ligands
    • Transporter Ligands
    Icon image 2
    Bioactive Screening Compound Libraries
    • Bioactive Compounds I
    • Bioactive Compounds II
    • Bioactive Compounds III
    • Bioactive Compounds Max
    • Flavour and Fragrance Compounds
    • High-Potency Chemical Probes
    • Natural Product Derivatives
    • Natural Products
    • QED Bioactive Compounds
    • Traditional Chinese Medicine Active Compounds
    Icon image 4
    Disease Related Compound Libraries
    • Anticancer Compounds
    • Antiviral Compounds
    • Cardiotoxic Compounds
    • Most-DILI-Concern Drugs
    • Neurodegenerative Disease Related Compounds
    • Psychoactive Drugs
    Icon image 3
    Drug Repurposing and Related Libraries
    • Approved Drugs
    • FDA Approved and Potential Drugs
    • FDA Approved Drugs
    • Full Library of FDA Approved Drugs
    • Impurity Reference Standards
    • Investigational Drugs
  • Products
    Libraries
    Signaling Pathways and Protein Classes Related LibrariesDisease Related Compound LibrariesBioactive Screening Compound LibrariesDrug Repurposing and Related Libraries
    Categorized products
    AgonistsInhibitors
    Reagents for Chemical Biology
    Bioorthogonal ReagentsPhotoaffinity Labeling (PAL)
    Bioorthogonal ReagentsPhotoaffinity Labeling (PAL)Drugs & Investigational CompoundsExploratory Compounds & Research ToolsMarine ProductsPesticides and pollutantsPfizer Reference CompoundsAntiviral Compounds
    Drugs and impuritiesChemical probes
  • Drugs & Impurities
  • Chemical probes
  • Services
  • Search
  • Compound libraries

    Arrow active
  • Products

    Arrow active
  • EBC main page

  • Search

  • Impurities

  • Chemical probes

  • Contact

  • Services

Welcome back

Please sign in using
Enamine Store account credentials

Enamie Logo
Email *
Password *
show
Forgot password?
Don’t have an account? Sign Up
Logo
Enamine store logo
Logo
  • Terms of Service
  • Privacy Policy
  • Publications
  • Contact us
  • About us
Enamine store logo

© 2026 Copyright Enamine

Back

EBCL-0001

Bioactive Compounds I

Bioactive Library I: we have synthesized and collected 11254 compounds with known biological activity, including over 1100 FDA-approved drugs, tool compounds, metabolites, prodrugs, and drug candidates.

  • Fully annotated: all compounds are provided with literature references and detailed and up to date biological activity data.
  • Custom Synthesis and Compound Sourcing: we can supply almost any compound either via in-house synthesis or using our supplier network.


Related terms: GPCR, carbonic anhydrase, ligand-gated ion channel, receptor tyrosine kinase, RTK, nRTK, cytochrome P450, voltage-gated ion channel, oxidoreductase, catecholamine turnover

Library image center

Preplated options

Dry powder/solution (DMSO)Dry powder
Number of compounds11254
Comment
Dry powder/solution (DMSO)DMSO solution
Number of compounds5360
Comment

Highlights

Molecule highlight
EBC-09069CAS: 1628210-26-3

KDM5-IN-1 is a potent, selective and orally bioavailable KDM5 inhibitor, IC50 = 14nM.

Molecule highlight
EBC-07684CAS: 872628-31-4

Compound shows binding affinity to adenosine receptor a2a, Ki = 1.21 µM.

Molecule highlight
EBC-03833CAS: 91374-20-8

Ropinirole is a non-ergoline dopamine agonist. It is used for the treatment of the signs and symptoms of Parkinson's disease

Molecule highlight
EBC-11393CAS: 842133-18-0

Canagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor used to manage hyperglycemia in type 2 diabetes mellitus

Get an individual offer

We propose the complete list of Services powered by Enamine

Select size
Select format
Disclaimer

All our products are for research purpose only. Any personal or non-scientific use is strictly prohibited.

Note

All the compounds with solubility below 10 mM are shipped as 2 mM solutions.

Product Features

  • Enamine Bioactive Library I is a set of 11254 bioactive molecules for HTS/HCS programs.
  • The Bioactive Library I covers novel promising preclinical lead compounds, clinical candidates and approved drugs.
  • Comprehensive documentation with structures, trivial names, synonyms, activity coefficient values, types of action on target and references to original literature.
  • NMR and LCMS validated purity.
  • All the compounds are available in stock for hit follow-up.
  • The library is continuously updated.

Product Details

  • Format: 10 - 100 µL of 10 mM DMSO stock solutions; dry powders (1 mg);
  • Container: 384-well microplates;
  • Storage: - 18 °C;
  • Shipping: Dry ice.

Utility

  • High throughput screening (HTS);
  • High content screening (HCS);
  • Cherry picking.

Library Composition

Name
Occurrence in the library, times

G protein-coupled receptors

1230

1230

Number of compounds

1230

Carbonic anhydrases

668

668

Number of compounds

668

Ligand-gated ion channels

299

299

Number of compounds

299

Receptor tyrosine kinases (RTKs)

248

248

Number of compounds

248

Cytochrome P450

175

175

Number of compounds

175

Voltage-gated ion channels

160

160

Number of compounds

160

1.-.-.- Oxidoreductases

143

143

Number of compounds

143

Non-receptor tyrosine kinases (nRTKs)

138

138

Number of compounds

138

Catecholamine turnover

134

134

Number of compounds

134

Eicosanoid turnover

131

131

Number of compounds

131

Steroid hormone receptors

121

121

Number of compounds

121

Potassium channels

118

118

Number of compounds

118

Acetylcholine turnover

112

112

Number of compounds

112

Chromatin modifying enzymes

104

104

Number of compounds

104

Hydrolases

89

89

Number of compounds

89

SLC6 neurotransmitter transporter family

84

84

Number of compounds

84

Nuclear hormone receptors

81

81

Number of compounds

81

ATP-binding cassette transporter family

64

64

Number of compounds

64

MA: Metallo (M) Peptidases

63

63

Number of compounds

63

Endocannabinoid turnover

62

62

Number of compounds

62

SLC superfamily of solute carriers

61

61

Number of compounds

61

Poly ADP-ribose polymerases

59

59

Number of compounds

59

L-Arginine turnover

55

55

Number of compounds

55

Orphan and other 7TM receptors

53

53

Number of compounds

53

SLC22 family of organic cation and anion transporters

52

52

Number of compounds

52

Mitogen-activated protein kinases (MAP kinases)

45

45

Number of compounds

45

Sigma receptors

44

44

Number of compounds

44

PA: Serine (S) Peptidases

43

43

Number of compounds

43

MG: Metallo (M) Peptidases

42

42

Number of compounds

42

Chloride channels

38

38

Number of compounds

38

CA: Cysteine (C) Peptidases

37

37

Number of compounds

37

CAMK: Calcium/calmodulin-dependent protein kinases

35

35

Number of compounds

35

Cyclic nucleotide turnover/signalling

34

34

Number of compounds

34

Glycogen synthase kinase (GSK) family

32

32

Number of compounds

32

Cyclin-dependent kinase (CDK) family

31

31

Number of compounds

31

CAMK-like (CAMKL) family

26

26

Number of compounds

26

CMGC: Containing CDK, MAPK, GSK3, CLK families

25

25

Number of compounds

25

Aryl hydrocarbon receptor complex

24

24

Number of compounds

24

AGC: Containing PKA, PKG, PKC families

23

23

Number of compounds

23

Catalytic receptors

22

22

Number of compounds

22

SC: Serine (S) Peptidases

19

19

Number of compounds

19

Lanosterol biosynthesis pathway

19

19

Number of compounds

19

Tubulins

18

18

Number of compounds

18

1.13.11.- Dioxygenases

18

18

Number of compounds

18

IKK family

18

18

Number of compounds

18

CK1: Casein kinase 1

17

17

Number of compounds

17

Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase (DYRK) family

17

17

Number of compounds

17

CD: Cysteine (C) Peptidases

17

17

Number of compounds

17

STE20 family

16

16

Number of compounds

16

Pattern recognition receptors

15

15

Number of compounds

15

Glycerophospholipid turnover

15

15

Number of compounds

15

E3 ubiquitin ligase components

14

14

Number of compounds

14

STE: Homologs of yeast Sterile 7, Sterile 11, Sterile 20 kinases

14

14

Number of compounds

14

Protein kinase C (PKC) family

14

14

Number of compounds

14

RAF family

13

13

Number of compounds

13

Casein kinase 2 (CK2) family

12

12

Number of compounds

12

Heat shock proteins

11

11

Number of compounds

11

Bromodomain-containing proteins

11

11

Number of compounds

11

Receptor serine/threonine kinase (RSTK) family

11

11

Number of compounds

11

RSK family

10

10

Number of compounds

10

DMPK family

10

10

Number of compounds

10

MH: Metallo (M) Peptidases

10

10

Number of compounds

10

Adenosine turnover

9

9

Number of compounds

9

Transcription factors

9

9

Number of compounds

9

Viral protein targets

9

9

Number of compounds

9

Interleukin-1 receptor-associated kinase (IRAK) family

9

9

Number of compounds

9

NADPH oxidases

9

9

Number of compounds

9

SLC28 and SLC29 families of nucleoside transporters

8

8

Number of compounds

8

Aurora kinase (Aur) family

8

8

Number of compounds

8

AA: Aspartic (A) Peptidases

8

8

Number of compounds

8

G protein-coupled receptor kinases (GRKs)

8

8

Number of compounds

8

Alpha kinase family

8

8

Number of compounds

8

Ceramide turnover

7

7

Number of compounds

7

Phosphatidyl inositol 3' kinase-related kinases (PIKK) family

7

7

Number of compounds

7

Leucine-rich repeat kinase (LRRK) family

7

7

Number of compounds

7

Carrier proteins

6

6

Number of compounds

6

IRE family

6

6

Number of compounds

6

SLC5 family of sodium-dependent glucose transporters

6

6

Number of compounds

6

LIM domain kinase (LISK) family

6

6

Number of compounds

6

DNA topoisomerases

6

6

Number of compounds

6

SLC2 family of hexose and sugar alcohol transporters

6

6

Number of compounds

6

PB: Threonine (T) Peptidases

6

6

Number of compounds

6

GABA turnover

5

5

Number of compounds

5

1.14.13.9 Kynurenine 3-monooxygenase

5

5

Number of compounds

5

NAK family

5

5

Number of compounds

5

3.2.1.- Glycosidases

4

4

Number of compounds

4

MC: Metallo (M) Peptidases

4

4

Number of compounds

4

Mixed Lineage Kinase (MLK) family

4

4

Number of compounds

4

Bromodomain kinase (BRDK) family

4

4

Number of compounds

4

Amino acid hydroxylases

4

4

Number of compounds

4

Numb-associated kinase (NAK) family

4

4

Number of compounds

4

F-type and V-type ATPases

4

4

Number of compounds

4

5.2.-.- Cis-trans-isomerases

4

4

Number of compounds

4

MAPK-Activated Protein Kinase (MAPKAPK) family

4

4

Number of compounds

4

SLC1 family of amino acid transporters

4

4

Number of compounds

4

CD molecules

4

4

Number of compounds

4

WEE family

3

3

Number of compounds

3

1.4.3.13 Lysyl oxidases

3

3

Number of compounds

3

Fatty acid-binding proteins

3

3

Number of compounds

3

Polo-like kinase (PLK) family

3

3

Number of compounds

3

Inositol phosphate turnover

3

3

Number of compounds

3

2.1.1.- Methyltransferases

3

3

Number of compounds

3

Nucleotide turnover

3

3

Number of compounds

3

Immunoglobulin like domain containing proteins

2

2

Number of compounds

2

Lipid modifying kinases

2

2

Number of compounds

2

TKL-unique family

2

2

Number of compounds

2

Receptor interacting protein kinase (RIPK) family

2

2

Number of compounds

2

P-type ATPases

2

2

Number of compounds

2

Thyroid hormone turnover

2

2

Number of compounds

2

Cytokine receptor family

2

2

Number of compounds

2

Other ion channels

2

2

Number of compounds

2

Adiponectin receptors

2

2

Number of compounds

2

Haem oxygenase

2

2

Number of compounds

2

2.6.1.42 Branched-chain-amino-acid transaminase

2

2

Number of compounds

2

NIMA (never in mitosis gene a)- related kinase (NEK) family

2

2

Number of compounds

2

RIO family

2

2

Number of compounds

2

G-alpha family G(q) subfamily

1

1

Number of compounds

1

P2C P-type ATPases

1

1

Number of compounds

1

TTK family

1

1

Number of compounds

1

CAMKK family

1

1

Number of compounds

1

Carboxylases and decarboxylases

1

1

Number of compounds

1

Atypical

1

1

Number of compounds

1

Haspin family

1

1

Number of compounds

1

Phosphatases

1

1

Number of compounds

1

2.3.1.- Acyltransferases

1

1

Number of compounds

1

Mitochondrial-associated proteins

1

1

Number of compounds

1

Kelch-like proteins

1

1

Number of compounds

1

SLC3 and SLC7 families of heteromeric amino acid transporters (HATs)

1

1

Number of compounds

1

3.4.21.46 Complement factor D

1

1

Number of compounds

1

SB: Serine (S) Peptidases

1

1

Number of compounds

1

MP: Metallo (M) Peptidases

1

1

Number of compounds

1

SLC17 phosphate and organic anion transporter family

1

1

Number of compounds

1

Sphingosine 1-phosphate turnover

1

1

Number of compounds

1

Hydrogen sulphide synthesis

1

1

Number of compounds

1

2.4.2.1 Purine-nucleoside phosphorylase

1

1

Number of compounds

1

Show all